This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Castro-Gago, M. Articles by Rodríguez-Segade, S. Search for Related Content PubMed PubMed Citation Articles by Castro-Gago, M. Articles by Rodríguez-Segade, S. Social Bookmarking                         What's this?

Serum Carnitine Levels in Epileptic Children Before and During Treatment With Valproic Acid, Carbamazepine, and Phenobarbital

Departamento de Pediatria, Servicio de Neuropediatria, Complejo Hospitalario Universitario de Santiago de Compostela, Hospital General de Galicia

Jesús Eirís-Puñal, MD

Departamento de Pediatria, Servicio de Neuropediatria, Complejo Hospitalario Universitario de Santiago de Compostela, Hospital General de Galicia

Maria Inés Novo-Rodríguez, MD

Departamento de Pediatria, Servicio de Neuropediatria, Complejo Hospitalario Universitario de Santiago de Compostela, Hospital General de Galicia

José Couceiro, MD

Departamento de Pediatria, Servicio de Neuropediatria, Complejo Hospitalario Universitario de Santiago de Compostela, Hospital General de Galicia

Félix Camiña, PhD

Departamento de Bioquímica y Biologia Molecular, Facultad de Farmacia, Santiago de Compostela Spain

Santiago Rodríguez-Segade, PhD

Departamento de Bioquímica y Biologia Molecular, Facultad de Farmacia, Santiago de Compostela Spain

Serum levels of free, acyl, and total carnitine were determined in 32 patients with seizures, before and after 3, 6, and 12 months of treatment with valproic acid (17 patients), carbamazepine (10 patients), or phenobarbital (5 patients). In all three treated groups, both free and total carnitine levels showed a significant decline with respect to pretreatment levels. This decline was most marked and most consistent in patients treated with valproic acid. In 35% of the patients in this group, carnitine deficiency (ie, total camitine < 30 µmol/L) was observed by month 12. In none of the three groups were serum carnitine levels significantly correlated with the serum concentration of the drug. These findings suggest a need to monitor serum carnitine levels in children treated with any of these drugs. (J Child Neurol 1998;13:546-549).

Journal of Child Neurology, Vol. 13, No. 11, 546-549 (1998)
DOI: 10.1177/088307389801301104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Castro-Gago, C. Gomez-Lado, J. Eiris-Punal, I. Diaz-Mayo, and D. E. Castineiras-Ramos Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine J Child Neurol, January 1, 2010; 25(1): 32 - 35. [Abstract] [PDF]

				M. Anil, M. Helvaci, E. Ozbal, O. Kalenderer, A. B. Anil, and M. Dilek Serum and Muscle Carnitine Levels in Epileptic Children Receiving Sodium Valproate J Child Neurol, January 1, 2009; 24(1): 80 - 86. [Abstract] [PDF]

				S. Kurul, E. Dirik, and A. IIscan Serum Carnitine Levels During Oxcarbazepine and Carbamazepine Monotherapies in Children With Epilepsy J Child Neurol, August 1, 2003; 18(8): 552 - 554. [Abstract] [PDF]

				E. P. Brass Pivalate-Generating Prodrugs and Carnitine Homeostasis in Man Pharmacol. Rev., December 1, 2002; 54(4): 589 - 598. [Abstract] [Full Text] [PDF]